Patents by Inventor Herbert H. Silvestri

Herbert H. Silvestri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4351766
    Abstract: Trimethylsilyl or another easily hydrolyzed ester of 6-trimethylsilyloxycarbonylaminopenicillanic acid was prepared by bubbling dry carbon dioxide into an anhydrous solution of the corresponding 6-trimethylsilylaminopenicillanate and found to be a useful intermediate in the production of penicillins, e.g., amoxicillin and ampicillin, by its acylation in anhydrous media with the appropriate acid chloride or acid chloride hydrochloride.
    Type: Grant
    Filed: August 13, 1981
    Date of Patent: September 28, 1982
    Assignee: Bristol-Myers Company
    Inventors: Derek Walker, Herbert H. Silvestri, Chester Sapino, David A. Johnson
  • Patent number: 4316017
    Abstract: In the preferred embodiment of the present invention trimethylsilyl 7-trimethylsilyloxycarbonylaminodecephalosporanate was prepared by bubbling dry carbon dioxide into an anhydrous solution of trimethylsilyl 6-trimethylsilylaminodecephalosporanate and found to be a useful intermediate in the production of cefadroxil and cephalexin by its acylation in anhydrous media with the appropriate 2-phenylglycyl chloride hydrochloride. Other cephalosporins are produced by acylation of 7-trimethylsilyloxycarbonylaminoceph-3-em-4-carboxylic acids or esters having a variety of substituents at the 3-position.
    Type: Grant
    Filed: June 11, 1980
    Date of Patent: February 16, 1982
    Assignee: Bristol-Myers Company
    Inventors: Derek Walker, Herbert H. Silvestri, Chester Sapino, David A. Johnson
  • Patent number: 4316016
    Abstract: In the preferred embodiment of the present invention trimethylsilyl 7-trimethylsilyloxycarbonylaminodecephalosporanate was prepared by bubbling dry carbon dioxide into an ahydrous solution of trimethylsilyl 6-trimethylsilylaminodecephalosporanate and found to be a useful intermediate in the production of cefadroxil and cephalexin by its acylation in anhydrous media with the appropriate 2-phenylglycyl chloride hydrochloride. Other cephalosporins are produced by acylation of 7-trimethylsilyloxycarbonylaminoceph-3-em-4-carboxylic acids or esters having a variety of substituents at the 3-position.
    Type: Grant
    Filed: June 11, 1980
    Date of Patent: February 16, 1982
    Assignee: Bristol-Myers Company
    Inventors: Derek Walker, Herbert H. Silvestri, Chester Sapino, David A. Johnson
  • Patent number: 4310458
    Abstract: Trimethylsilyl or another easily hydrolyzed ester of 6-trimethylsilyloxycarbonylaminopenicillanic acid was prepared by bubbling dry carbon dioxide into an anhydrous solution of the corresponding 6-trimethylsilylaminopenicillanate and found to be a useful intermediate in the production of penicillins, e.g., amoxicillin and ampicillin, by its acylation in anhydrous media with the appropriate acid chloride or acid chloride hydrochloride.
    Type: Grant
    Filed: July 12, 1979
    Date of Patent: January 12, 1982
    Assignee: Bristol-Myers Company
    Inventors: Derek Walker, Herbert H. Silvestri, Chester Sapino, David A. Johnson
  • Patent number: 4278600
    Abstract: Trimethylsilyl or another easily hydrolyzed ester of 6-trimethylsilyloxycarbonylaminopenicillanic acid was prepared by bubbling dry carbon dioxide into ananhydrous solution of the corresponding 6-trimethylsilylaminopenicillanate and found to be a useful intermediate in the production of penicillins, e.g., amoxicillin and ampicillin, by its acylation in anhydrous media with the appropriate acid chloride or acid chloride hydrochloride.
    Type: Grant
    Filed: July 20, 1979
    Date of Patent: July 14, 1981
    Assignee: Bristol-Myers Company
    Inventors: Derek Walker, Herbert H. Silvestri, Chester Sapino, David A. Johnson
  • Patent number: 4240960
    Abstract: Trimethylsilyl or another easily hydrolyzed ester of 6-trimethylsilyloxycarbonylaminopenicillanic acid was prepared by bubbling dry carbon dioxide into an anhydrous solution of the corresponding 6-trimethylsilylaminopenicillanate and found to be a useful intermediate in the production of penicillins, e.g., amoxicillin and ampicillin, by its acylation in anhydrous media with the appropriate acid chloride or acid chloride hydrochloride.
    Type: Grant
    Filed: March 19, 1979
    Date of Patent: December 23, 1980
    Assignee: Bristol-Myers Company
    Inventors: Derek Walker, Herbert H. Silvestri, Chester Sapino, David A. Johnson
  • Patent number: 4223135
    Abstract: In the preferred embodiment of the present invention trimethylsilyl 7-trimethylsilyloxycarbonylaminodecephalosporanate was prepared by bubbling dry carbon dioxide into an anhydrous solution of trimethylsilyl 6-trimethylsilylaminodecephalosporanate and found to be a useful intermediate in the production of cefadroxil and cephalexin by its acylation in anhydrous media with the appropriate 2-phenylglycyl chloride hydrochloride. Other cephalosporins are produced by acylation of 7-trimethylsilyloxycarbonylaminoceph-3-em-4-carboxylic acids or esters having a variety of substituents at the 3-position.
    Type: Grant
    Filed: March 19, 1979
    Date of Patent: September 16, 1980
    Assignee: Bristol-Myers Company
    Inventors: Derek Walker, Herbert H. Silvestri, Chester Sapino, David A. Johnson
  • Patent number: 3941773
    Abstract: 1. A new crystalline form of D-6-(2-amino-2-phenyl-acetamido)penicillanic acid characterized by being substantially free of water in the chemically bound state, having a molecular weight of about 349, having an infrared spectrograph as disclosed in FIG. 1 of the drawings, and possessing substantially greater storage stability than hydrated crystalline D-6-(2-amino-2-phenyl-acetamido)penicillanic acid.
    Type: Grant
    Filed: November 2, 1964
    Date of Patent: March 2, 1976
    Assignee: Bristol-Myers Company
    Inventors: Herbert H. Silvestri, David A. Johnson